Revenue: The sum of all revenue fields included for a company's operating activities.
Ono Pharmaceutical Co. (OPHLF) had Revenue of $3.47B for the most recently reported fiscal year, ending 2024-03-31.
| Income Statement Financials | |
|
Revenue |
$3.47B |
$883.04M |
|
$877.17M |
|
$2.59B |
|
$2.36B |
|
$1.10B |
|
$26.21M |
|
$1.13B |
|
$1.13B |
|
$883.48M |
|
$883.48M |
|
$883.48M |
|
$883.48M |
|
$1.10B |
|
$1.23B |
|
480.01M |
|
480.01M |
|
$1.84 |
|
$1.84 |
|
| Balance Sheet Financials | |
$2.85B |
|
$722.79M |
|
$3.45B |
|
$6.30B |
|
$715.01M |
|
-- |
|
$78.93M |
|
$793.93M |
|
$5.51B |
|
$5.12B |
|
$5.51B |
|
469.65M |
|
| Cash Flow Statement Financials | |
$763.55M |
|
$331.73M |
|
$-619.95M |
|
$663.33M |
|
$1.15B |
|
$483.04M |
|
-- |
|
$-256.62M |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.99 |
|
-- |
|
-- |
|
-- |
|
-- |
|
74.71% |
|
31.82% |
|
31.82% |
|
35.43% |
|
32.57% |
|
25.46% |
|
$742.05M |
|
-- |
|
-- |
|
-- |
|
0.55 |
|
2.61 |
|
3.69 |
|
98.80 |
|
16.03% |
|
17.27% |
|
14.01% |
|
16.03% |
|
$11.73 |
|
$1.55 |
|
$1.59 |
|